Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | KB707 |
| Trade Name | |
| Synonyms | KB-707|KB 707 |
| Drug Descriptions |
KB707 is a vector derived from a replication-defective herpes simplex virus type 1 (HSV-1) and engineered to express IL-12 and IL-2, which potentially results in antitumor activity (Journal for ImmunoTherapy of Cancer 2023;11). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Docetaxel + KB707 | Docetaxel KB707 | 0 | 1 |
| KB707 | KB707 | 0 | 2 |
| KB707 + Pembrolizumab | KB707 Pembrolizumab | 0 | 1 |